Reasearch Awards nomination

Email updates

Keep up to date with the latest news and content from Critical Care and BioMed Central.

Open Access Research

Augmented renal clearance in septic and traumatized patients with normal plasma creatinine concentrations: identifying at-risk patients

Andrew A Udy12*, Jason A Roberts123, Andrew F Shorr4, Robert J Boots12 and Jeffrey Lipman12

Author Affiliations

1 Burns, Trauma, and Critical Care Research Centre, University of Queensland, Royal Brisbane and Womens Hospital, Butterfield Street, Herston 4029, Australia

2 Department of Intensive Care Medicine, Royal Brisbane and Womens Hospital, Butterfield Street, Herston 4029, Australia

3 Pharmacy Department, Royal Brisbane and Womens Hospital, Butterfield Street, Herston 4029, Australia

4 Pulmonary and Critical Care Medicine, Washington Hospital Center, 110 Irving Street NW, Washington DC 20010, USA

For all author emails, please log on.

Critical Care 2013, 17:R35  doi:10.1186/cc12544

Published: 28 February 2013

Abstract

Introduction

Improved methods to optimize drug dosing in the critically ill are urgently needed. Traditional prescribing culture involves recognition of factors that mandate dose reduction (such as renal impairment), although optimizing drug exposure, through more frequent or augmented dosing, represents an evolving strategy. Elevated creatinine clearance (CLCR) has been associated with sub-therapeutic antibacterial concentrations in the critically ill, a concept termed augmented renal clearance (ARC). We aimed to determine the prevalence of ARC in a cohort of septic and traumatized critically ill patients, while also examining demographic, physiological and illness severity characteristics that may help identify this phenomenon.

Methods

This prospective observational study was performed in a 30-bed tertiary level, university affiliated, adult intensive care unit. Consecutive traumatized and septic critically ill patients, receiving antibacterial therapy, with a plasma creatinine concentration ≤110 μmol/L, were eligible for enrolment. Pulse contour analysis (Vigileo / Flo Trac® system, Edwards Lifesciences, Irvine, CA, USA), was used to provide continuous cardiac index (CI) assessment over a single six-hour dosing interval. Urinary CLCR measures were obtained concurrently.

Results

Seventy-one patients contributed data (sepsis n = 43, multi-trauma n = 28). Overall, 57.7% of the cohort manifested ARC, although there was a greater prevalence in trauma (85.7% versus 39.5%, P <0.001). In all patients, a weak correlation was noted between CI and CLCR (r = 0.346, P = 0.003). This was mostly driven by septic patients (r = 0.508, P = 0.001), as no correlation (r = -0.012, P = 0.951) was identified in trauma. Those manifesting ARC were younger (P <0.001), male (P = 0.012), with lower acute physiology and chronic health evaluation (APACHE) II (P= 0.008) and modified sequential organ failure assessment (SOFA) scores (P = 0.013), and higher cardiac indices (P = 0.013). In multivariate analysis, age ≤50 years, trauma, and a modified SOFA score ≤4, were identified as significant risk factors. These had greater utility in predicting ARC, compared with CI assessment alone.

Conclusions

Diagnosis, illness severity and age, are likely to significantly influence renal drug elimination in the critically ill, and must be regularly considered in future study design and daily prescribing practice.

See related commentary by De Waele and Carlier, http://ccforum.com/content/17/2/130 webcite